drugset / Trial / NCT03365921
A Phase Ⅳ Clinical Trial of the Recombinant Hepatitis E Vaccine (Escherichia Coli)(the Lot Consistency Trial)
Phase 4
Completed
360 enrolled
Xiamen Innovax Biotech Co., Ltd
Jiangsu Province Centers for Disease Control and Prevention · collab
RandomizedParallel-groupTriple-blindPrevention
Summary
This study is to evaluate lot-lot consistency of Recombinant Hepatitis E Vaccine (Escherichia Coli) Hecolin®.
Timeline
- Start
- 2018-10-27
- Primary completion
- 2019-06-16
- Completion
- 2019-06-16
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Hecolin® | Vaccine | — | Intramuscular |